Trichoscopic Markers and Clinical Response Patterns With Ritlecitinib in Severe Alopecia Areata: 24‐Week Outcomes From a Prospective Real‐World Cohort

Documenti analoghi

• Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
  di: Işıl Deniz Oğuz, et al.
  Pubblicazione: (2025)
• Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
  di: Eda Öksüm Solak, et al.
  Pubblicazione: (2024)
• Objective and Subjective Assessments of the Response of Photobiomodulation Therapy Against Alopecia Areata
  di: Yi-Shan Liu, et al.
  Pubblicazione: (2026)
• Evaluation of the Efficacy and Safety of Oral Tofacitinib for the Treatment of Alopecia Areata in Children
  di: Robabeh Abedini, et al.
  Pubblicazione: (2024)
• Efficacy and Safety of Baricitinib in Patients With Alopecia Areata: A Real‐World Cohort Study
  di: Caiyu Wang, et al.
  Pubblicazione: (2025)